» Articles » PMID: 17081918

Mechanisms of Transcoelomic Metastasis in Ovarian Cancer

Overview
Journal Lancet Oncol
Specialty Oncology
Date 2006 Nov 4
PMID 17081918
Citations 261
Authors
Affiliations
Soon will be listed here.
Abstract

Metastasis from epithelial ovarian cancer can occur via the transcoelomic, haematogeneous, or lymphatic route. Of these, transcoelomic metastasis is the most common, and is responsible for the greatest morbidity and mortality in women with this disease. Unfortunately, very little is known about the mechanisms behind this process. This review assesses the current evidence and ideas about the biology of transcoelomic dissemination. The mechanisms of cell detachment, migration, and implantation in transcoelomic metastasis are placed within the context of clinical observations of ovarian cancer to derive a stepwise hypothesis of this process. Evidence for transcoelomic dissemination versus transcoelomic metaplasia in ovarian cancer is presented. Future high throughput microarray studies that compare changes at a genomic and gene expression level between primary ovarian tumours and their peritoneal metastases are hoped to lead to a more conclusive picture of transcoelomic metastasis, and to delineate the key molecular players in this process. These studies might also result in the identification of potential new therapeutic targets in ovarian cancer.

Citing Articles

Paired primary-metastasis patient-derived organoids and mouse models identify phenotypic evolution and druggable dependencies of peritoneal metastasis from appendiceal cancer.

Mahmoud A, Choi P, Sukhwa C, Pintar J, Walch H, Zhao N bioRxiv. 2025; .

PMID: 40027618 PMC: 11870485. DOI: 10.1101/2025.02.17.638725.


Microbes, macrophages, and melanin: a unifying theory of disease as exemplified by cancer.

Berg S, Berg J Front Immunol. 2025; 15:1493978.

PMID: 39981299 PMC: 11840190. DOI: 10.3389/fimmu.2024.1493978.


PI3Kα-specific inhibitor BYL-719 synergizes with cisplatin in vitro in PIK3CA-mutated ovarian cancer cells.

Thibault B, Thole A, DAngelo R, Basset C, Guillermet-Guibert J Sci Rep. 2025; 15(1):6265.

PMID: 39979449 PMC: 11842864. DOI: 10.1038/s41598-025-90714-9.


Predictive impact of clinical factors on chemosensitivity in advanced high-grade serous ovarian carcinoma according to chemotherapy response score.

Park M, Shin W, Lim M, Park S, Yoo C, Kim K Medicine (Baltimore). 2025; 103(47):e40487.

PMID: 39809172 PMC: 11596952. DOI: 10.1097/MD.0000000000040487.


Neutrophil extracellular traps promote pre-metastatic niche formation in the omentum by expanding innate-like B cells that express IL-10.

Lee W, Ko S, Akasaka H, Weigert M, Lengyel E, Naora H Cancer Cell. 2025; 43(1):69-85.e11.

PMID: 39753138 PMC: 11732717. DOI: 10.1016/j.ccell.2024.12.004.